Does hyperprolaetinaemia predispose to aluminium toxicity in chronic renal failure?
Thomas H. Corbett(Lister Hospital), K. Farrington(Lister Hospital), James Tattersall, Roger Greenwood(Mount Sinai Beth Israel), D. de Takats(Lister Hospital)
Cited by 0
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Vascular access use in Europe and the United States: Results from the DOPPS
|Kidney International|2002|855
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
|Nephrology Dialysis Transplantation|2013|476
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2003|472
Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy
|Nephrology Dialysis Transplantation|2010|426